User profiles for Raman Sharma

Raman Sharma

PGIMER Chandigarh
Verified email at pgimer.edu.in
Cited by 517

Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria

…, RK Amewu, SC Leung, R Sharma… - Proceedings of the …, 2012 - National Acad Sciences
There is an urgent need for new antimalarial drugs with novel mechanisms of action to deliver
effective control and eradication programs. Parasite resistance to all existing antimalarial …

Clinical characteristics and differential clinical diagnosis of novel coronavirus disease 2019 (COVID-19)

R Sharma, M Agarwal, M Gupta, S Somendra… - … Disease 2019 (COVID …, 2020 - Springer
Novel Coronavirus Disease (COVID-19) has become a rapidly growing pandemic involving
several nations. It is of serious concern and extreme challenge not only to the health …

Highly selective inhibition of human CYP3A in vitro by azamulin and evidence that inhibition is irreversible

…, T Ho, CE Cargill, AP Blanchard, R Sharma… - Drug Metabolism and …, 2004 - ASPET
Azamulin [14-O-(5-(2-amino-1,3,4-triazolyl)thioacetyl)-dihydromutilin] is an azole derivative
of the pleuromutilin class of antiinfectives. We tested the inhibition potency of azamulin …

Clinical profile of Covid-19 infected patients admitted in a tertiary care hospital in North India.

…, S Sharma, P Keshwani, R Sharma… - The Journal of the …, 2020 - europepmc.org
Background The novel coronavirus (Covid-19) continues to wreck havoc across China,
European countries, USA and now seems to gain a strong foothold in India. The aim of this report …

Identification, Design and Biological Evaluation of Bisaryl Quinolones Targeting Plasmodium falciparum Type II NADH:Quinone Oxidoreductase (PfNDH2)

…, SC Leung, NG Berry, R Sharma… - Journal of medicinal …, 2012 - ACS Publications
A program was undertaken to identify hit compounds against NADH:ubiquinone oxidoreductase
(PfNDH2), a dehydrogenase of the mitochondrial electron transport chain of the malaria …

Antisense oligonucleotides: modifications and clinical trials

VK Sharma, RK Sharma, SK Singh - MedChemComm, 2014 - pubs.rsc.org
There has been an upsurge in the number of clinical trials involving chemically modified
oligonucleotide-based drug candidates after the FDA approval of Vitravene, Macugen, and …

Optimizing PK properties of cyclic peptides: the effect of side chain substitutions on permeability and clearance

AC Rand, SSF Leung, H Eng, CJ Rotter, R Sharma… - …, 2012 - pubs.rsc.org
A series of cyclic peptides were designed and prepared to investigate the physicochemical
properties that affect oral bioavailabilty of this chemotype in rats. In particular, the ionization …

Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of ((S)-2,2-Difluorocyclopropyl)((1R,5S)-3-(2-((1-methyl-1H-pyrazol-4-yl) …

…, TH Lin, BS Pierce, E Saiah, R Sharma… - Journal of medicinal …, 2018 - ACS Publications
Cytokine signaling is an important characteristic of autoimmune diseases. Many pro-inflammatory
cytokines signal through the Janus kinase (JAK)/Signal transducer and activator of …

The impact of incinerators on human health and environment

R Sharma, M Sharma, R Sharma… - … on environmental health, 2013 - degruyter.com
Of the total wastes generated by health-care organizations, 10%–25% are biomedical wastes,
which are hazardous to humans and the environment and requires specific treatment and …

Pharmacokinetics, metabolism, and excretion of the antidiabetic agent ertugliflozin (PF-04971729) in healthy male subjects

Z Miao, G Nucci, N Amin, R Sharma, V Mascitti… - Drug Metabolism and …, 2013 - ASPET
The disposition of ertugliflozin (PF-04971729), an orally active selective inhibitor of the
sodium-dependent glucose cotransporter 2, was studied after a single 25-mg oral dose of [ 14 C]-…